The Progressive Corporation, as a leading insurance provider, displays a resilient business model with diversified product offerings in personal and commercial insurance sectors. This positions the company well in a competitive market. The stock shows stability but profitability metrics indicate room for improvement. Analyst perspectives suggest a mixed outlook.
The current fundamental analysis of The Progressive Corporation indicates a balanced score, reflecting moderate financial health and growth potential.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 3 | |
| Return on Equity | 5 | |
| Return on Assets | 5 | |
| Debt to Equity | 3 | |
| Price to Earnings | 2 | |
| Price to Book | 1 |
The historical data gives insight into the stock's previous performance, highlighting stability in fundamental ratings over recent periods.
| Date | Overall Score | DCF | ROE | ROA | Debt to Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-09-15 | 3 | 3 | 5 | 5 | 3 | 2 | 1 |
| Previous Date | 0 | 3 | 5 | 5 | 3 | 2 | 1 |
The stock exhibits a consensus view of holding, with a diverse price target range indicating varying market expectations.
| High | Low | Median | Consensus |
|---|---|---|---|
| 328 | 267 | 297.5 | 297.5 |
Analyst sentiment reflects a general holding pattern, suggesting caution alongside potential growth opportunities.
| Recommendation | Count | Distribution |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 18 | |
| Hold | 19 | |
| Sell | 3 | |
| Strong Sell | 0 |
The Progressive Corporation appears to maintain a well-balanced position within the insurance sector. Its mixed fundamental ratings suggest a need for strategic enhancements, while historical data supports its consistent performance. Analysts present a cautious yet stable forecast with a hold consensus. Investors should consider the dynamic market conditions and potential for diversification in assessing investment viability.
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.